Clozapine: Conference Sessions
14 sessions at 7 meetings. Clozapine use, monitoring, REMS, adverse effects.
Meetings covering clozapine
| AACAP Annual Meeting 2026 | October 26–31, 2026 | 4 sessions → |
| MGH 50th Annual Psychopharmacology Conference | October 16–18, 2026 | 3 sessions → |
| APNA 40th Annual Conference | October 28–31, 2026 | 1 session → |
| NEI Fall Congress 2026 | November 5–8, 2026 | 1 session → |
| NPA 32nd Annual Psychopharmacology Update 2027 | February 10–13, 2027 | 1 session → |
| Psych Congress 2026 | September 15–19, 2026 (past) | 3 sessions → |
| WCP 2026 — 26th World Congress of Psychiatry | September 23–26, 2026 (past) | 1 session → |
Top speakers on clozapine
Oliver Freudenreich · Brent Beck · Jonathan M. Meyer · Tatum Burdo
Upcoming
MGH 50th Annual Psychopharmacology Conference
- WorkshopClozapine Workshop
Hands-on ticketed workshop on initiating, monitoring, and troubleshooting clozapine treatment.
- LectureClozapine Basics
Introductory overview of the fundamentals of using clozapine in clinical practice.
- LectureClinical Vignettes with Question & Answer
Case-based vignettes illustrating practical clozapine management, followed by audience questions and answers.
AACAP Annual Meeting 2026
- SymposiumStuck at the Crossroads: Management of Treatment-Resistant Schizophrenia in Youth
Henry Teaford · Brent Beck · Tatum Burdo · Shruti Tilak
Clinical perspectives session on managing treatment-resistant schizophrenia in children and adolescents, including when and how to move to clozapine and other next-step strategies.
- LectureClozapine Augmentation With Antipsychotic and Nonantipsychotic Agents
Covers strategies for augmenting clozapine with other antipsychotic and non-antipsychotic medications in youth with treatment-resistant schizophrenia.
- LectureChanging the Trajectory: Clozapine in Pediatric Treatment-Resistant Schizophrenia
Discusses the role of clozapine in treating pediatric treatment-resistant schizophrenia and its effect on outcomes.
- PosterClozapine in Complex Pediatric Neurodevelopmental Disorders: Behavioral Stabilization, Seizure Burden, and Safety Monitoring
Geetha Ravindranathan · Amandeep Singh · Danielle Smith
Looks at clozapine use in youth with complex neurodevelopmental disorders, covering behavioral outcomes, seizure burden and safety monitoring.
APNA 40th Annual Conference
- LectureClozapine Knowledge, Confidence, and Prescribing Practices Among Advanced Practice Psychiatric Nurses: Results of a National Study
Brayden Kameg · Rezvaneh Manzour
National study mapping clozapine knowledge gaps and prescribing patterns among advanced practice psychiatric nurses. Pharmacology-eligible.
NEI Fall Congress 2026
- SymposiumOld Time Pharmaco: Contemporary Evidence for Retiring Older Therapies and Optimizing Clozapine and Lithium Use
Reviews older psychotropics with limited modern utility and current best practices for clozapine and lithium.
NPA 32nd Annual Psychopharmacology Update 2027
- LectureClozapine Monitoring Post REMS
How clozapine prescribing and hematologic monitoring change after the end of the REMS program.
Past meetings
WCP 2026 — 26th World Congress of Psychiatry
- SymposiumUpdate on Clozapine: Effectiveness, Safety Profile, (under-)utilisation, and Strategies for Improved Utilisation
Reviews clozapine's evidence base, safety monitoring, and approaches to address global underuse.
Psych Congress 2026
- SymposiumSuicide Prevention in Psychiatric Practice: A Logical, Evidence-Based Framework
Jill Harkavy-Friedman · Cory Weissman
Reviews treatments with demonstrated anti-suicidal benefit — lithium, clozapine, ECT, and CBT-based approaches — within a structured framework for individualized prevention planning. Developed with the American Foundation for Suicide Prevention.
Lithium & Mood StabilizersNeuromodulation (ECT, TMS)Suicide & Self-Harm
- LectureDifficult Medicines: Navigating the Complexities of Clozapine
Deep dive into clozapine for treatment-resistant schizophrenia — initiation, monitoring requirements, side-effect management, and adherence — grounded in real-world cases.
- DebateWhen Standard Treatment Isn't Enough: Complex Schizophrenia Cases and Clinical Decision-Making
Leslie Citrome · Erin Crown · Brooke Kempf
Panel works through challenging schizophrenia cases involving treatment resistance and functional decline, covering sequencing, clozapine timing, augmentation, and metabolic and sedation trade-offs.
Antipsychotic PrescribingGLP-1 & Metabolic PsychiatrySchizophrenia & Psychosis
Browse the directory
By date
By specialty
- General Psychiatry
- Psychopharmacology
- Child & Adolescent Psychiatry
- Addiction Psychiatry
- Geriatric Psychiatry
- Forensic Psychiatry
- Consultation-Liaison Psychiatry
- Anxiety & Depression
- Neuroscience
- Psychiatric Nursing / PMHNP
- ADHD
- Bipolar Disorders
- Schizophrenia & Psychosis
- Trauma & PTSD
- Women's & Perinatal Mental Health
- Psychotherapy
- Emergency Psychiatry
- Interventional Psychiatry & Neuromodulation
- Psychedelic Medicine
- Suicide Prevention
- OCD & Related Disorders
- Autism Spectrum
- Sleep Medicine
By location
- International
- Midwest US
- Northeast US
- Southern US
- Western US
- California (6)
- Colorado (4)
- San Diego (4)
- Chicago (3)
- Denver (3)
- Florida (3)
- Illinois (3)
- Washington (3)
- Washington, D.C. (3)
- Arizona (2)
- Atlanta (2)
- Boston (2)
- Georgia (2)
- Hawaii (2)
- Massachusetts (2)
- New York (2)
- New Zealand (2)
- Tennessee (2)
- Texas (2)
- Albuquerque (1)
- Asheville (1)
- Auckland (1)
- Austin (1)
- Baltimore (1)
- Brazil (1)
- Canada (1)
- Cape Town (1)
- Christchurch (1)
- Colorado Springs (1)
- Dallas (1)
- Florence (1)
- France (1)
- Glasgow (1)
- Italy (1)
- Kapolei (1)
- Kentucky (1)
- Koloa (Kauai) (1)
- Lake Buena Vista (1)
- Las Vegas (1)
- Louisiana (1)
- Louisville (1)
- Lyon (1)
- Maryland (1)
- Memphis (1)
- Montreal (1)
- Napa (1)
- Nashville (1)
- Nevada (1)
- New Mexico (1)
- New Orleans (1)
- Newport Beach (1)
- North Carolina (1)
- Orlando (1)
- Phoenix (1)
- Reston (1)
- Rio de Janeiro (1)
- Scottsdale (1)
- South Africa (1)
- Tampa (1)
- United Kingdom (1)
- Virginia (1)
By type
By audience
Speakers & topics
Recurring meetings
- All conference series
- AAAP Annual Meeting and Scientific Symposium
- AACAP Annual Meeting
- AADPRT Annual Meeting
- AAGP Annual Meeting
- AAPL Annual Meeting
- AAPP Annual Meeting
- AAS Annual Conference
- ACLP Annual Meeting
- ACNP Annual Meeting
- ADAA Annual Conference
- AGPA Connect
- AMERSA Annual National Conference
- ANPA Annual Meeting
- APA Annual Meeting
- APNA Annual Conference
- APNA Clinical Psychopharmacology Institute
- APSARD Annual Conference
- APsA National Meeting
- ASAM Annual Conference
- ASCP Annual Meeting
- ASKP3 Annual Conference
- Annual International Conference on ADHD
- Annual OCD Conference
- Best Practices for Mood Disorders
- CINP World Congress of Neuropsychopharmacology
- Child & Adolescent Psychopharmacology (MGH Psychiatry Academy)
- ECNP Congress
- European Congress of Psychiatry
- IEPA International Conference on Early Intervention in Mental Health
- INSAR Annual Meeting
- ISBD Annual Conference
- ISPN Annual Conference
- ISTSS Annual Meeting
- International Brain Stimulation Conference
- International Marcé Society Biennial Conference
- MGH Annual Conference on Psychedelics and Psychedelic Medicine
- MGH Annual Psychopharmacology Conference
- MasterPsych Child & Adolescent Psychiatry Conference
- MasterPsych Psychiatry Conference
- Mayo Clinic Psychiatry Clinical Updates
- Medical Psychiatry: Comprehensive Update Conference
- NEI Congress
- NPA National Psychopharmacology Update
- NPACE Napa: Mental Health & Women's Health Conference
- National Update on Behavioral Emergencies (NUBE)
- Postpartum Support International Annual Conference
- Psych Congress
- Psych Congress NP Institute
- Psychedelic Science
- RANZCP Congress
- RCPsych International Congress
- SBSM Annual Meeting (formerly American Psychosomatic Society Annual Meeting)
- SIRS Congress
- SLEEP Annual Meeting (APSS)
- SOBP Annual Meeting
- Substance Use Disorders: A Comprehensive Review and Update
- WFSBP World Congress of Biological Psychiatry
- World Congress of Psychiatry